Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 415

1.

A new scenario in metastatic renal cell carcinoma: a SOG-GU consensus.

Vázquez Estévez S, Anido U, Lázaro M, Fernández O, Fernández Núñez N, de Dios Álvarez N, Varela V, Campos Balea B, Agraso S, Areses MC, Iglesias L, Blanco M, Maciá S, Anton Aparicio LM.

Clin Transl Oncol. 2020 Feb 15. doi: 10.1007/s12094-020-02300-2. [Epub ahead of print] Review.

PMID:
32062835
2.

Primary Care Doctor Characteristics That Determine the Use of Teleconsultations in the Catalan Public Health System: Retrospective Descriptive Cross-Sectional Study.

Fernández OS, Seguí FL, Vidal-Alaball J, Bonet Simo JM, Vian OH, Cabo PR, Hernandez MC, Dominguez CO, Reig XA, Rodríguez YD, Peralta MM, Hermosilla E, León NM, Guimferrer N, González MA, Cuyàs FG, Sust PP.

JMIR Med Inform. 2020 Jan 31;8(1):e16484. doi: 10.2196/16484.

3.

Woody Plant Declines. What's Wrong with the Microbiome?

Bettenfeld P, Fontaine F, Trouvelot S, Fernandez O, Courty PE.

Trends Plant Sci. 2020 Jan 23. pii: S1360-1385(19)30349-8. doi: 10.1016/j.tplants.2019.12.024. [Epub ahead of print] Review.

PMID:
31983620
4.

[Recommendations for the use of cladribine tablets in recurring multiple sclerosis].

Oreja-Guevara C, García-Merino JA, Saiz A, Rodríguez-Antigüedad A, Álvarez-Cermeño JC, Estrada-Pérez V, Izquierdo G, Fernández O.

Rev Neurol. 2019 Dec 17;69(s02):1-9. doi: 10.33588/rn.69s02.2019380. Review. Spanish.

PMID:
31933293
5.

Dry anaerobic digestion of organic waste: A review of operational parameters and their impact on process performance.

Rocamora I, Wagland ST, Villa R, Simpson EW, Fernández O, Bajón-Fernández Y.

Bioresour Technol. 2020 Mar;299:122681. doi: 10.1016/j.biortech.2019.122681. Epub 2019 Dec 24. Review.

6.

Profiles of local and systemic inflammation in the outcome of treatment of human cutaneous leishmaniasis caused by L. Viannia.

Navas A, Fernández O, Gallego-Marín C, Del Mar Castro M, Rosales-Chilama M, Murillo J, Cossio A, McMahon-Pratt D, Gore Saravia N, Gómez MA.

Infect Immun. 2019 Dec 9. pii: IAI.00764-19. doi: 10.1128/IAI.00764-19. [Epub ahead of print]

PMID:
31818959
7.

Efficacy of alemtuzumab in relapsing-remitting MS patients who received additional courses after the initial two courses: Pooled analysis of the CARE-MS, extension, and TOPAZ studies.

Comi G, Alroughani R, Boster AL, Bass AD, Berkovich R, Fernández Ó, Kim HJ, Limmroth V, Lycke J, Macdonell RA, Sharrack B, Singer BA, Vermersch P, Wiendl H, Ziemssen T, Jacobs A, Daizadeh N, Rodriguez CE, Traboulsee A; CARE-MS I, CARE-MS II, CAMMS03409, and TOPAZ Investigators.

Mult Scler. 2019 Nov 25:1352458519888610. doi: 10.1177/1352458519888610. [Epub ahead of print]

PMID:
31762387
8.

Veterinary Spanish Students' Attitude Toward Presumed Consent in Organ Donation.

Martínez-Alarcón L, Ríos A, Ramis G, Gómez-Laguna J, Moll X, Falceto V, San Román-Acaso F, San Román-Llorens F, Quereda JJ, Herrero Medrano JM, Mendonça L, Martin-Barrasa JL, Fernández OM, Muñoz A, Ramírez P, Parrilla P.

Transplant Proc. 2019 Nov;51(9):3004-3007. doi: 10.1016/j.transproceed.2019.08.018.

PMID:
31711582
9.

Efficacy of alemtuzumab over 6 years in relapsing-remitting multiple sclerosis patients who relapsed between courses 1 and 2: Post hoc analysis of the CARE-MS studies.

Van Wijmeersch B, Singer BA, Boster A, Broadley S, Fernández Ó, Freedman MS, Izquierdo G, Lycke J, Pozzilli C, Sharrack B, Steingo B, Wiendl H, Wray S, Ziemssen T, Chung L, Margolin DH, Thangavelu K, Vermersch P.

Mult Scler. 2019 Nov 1:1352458519881759. doi: 10.1177/1352458519881759. [Epub ahead of print]

PMID:
31675266
10.

Discontinuation of non-Vitamin K antagonist oral anticoagulants in patients with non-valvular atrial fibrillation: a population-based cohort study using primary care data from The Health Improvement Network in the UK.

Ruigómez A, Vora P, Balabanova Y, Brobert G, Roberts L, Fatoba S, Fernandez O, García Rodríguez LA.

BMJ Open. 2019 Oct 18;9(10):e031342. doi: 10.1136/bmjopen-2019-031342.

11.

Left Ventricular Filling Pressures Contribute to Exercise Limitation in Patients with Continuous Flow Left Ventricular Assist Devices.

Koshy A, Cruz NB, Okwose NC, Fernandez OG, Green T, Woods A, Robinson-Smith N, Tovey S, McDiarmid A, Parry G, Schueler S, Jakovljevic DG, MacGowan GA.

ASAIO J. 2019 Oct 30. doi: 10.1097/MAT.0000000000001073. [Epub ahead of print]

PMID:
31569116
12.

Perception of stigma in patients with primary progressive multiple sclerosis.

Pérez-Miralles F, Prefasi D, García-Merino A, Ara JR, Izquierdo G, Meca-Lallana V, Gascón F, Martínez-Ginés ML, Ramió-Torrentà L, Costa-Frossard L, Fernández Ó, Moreno-García S, Maurino J, Casanova-Estruch B.

Mult Scler J Exp Transl Clin. 2019 May 22;5(2):2055217319852717. doi: 10.1177/2055217319852717. eCollection 2019 Apr-Jun.

13.

Review of the novelties presented at the 2018 ECTRIMS Congress: 11th Post-ECTRIMS Meeting (II).

Fernandez O, Tintore M, Saiz A, Calles-Hernandez MC, Comabella M, Ramio-Torrenta L, Oterino A, Izquierdo G, Tellez N, Garcia-Merino JA, Brieva L, Arnal-Garcia C, Aladro Y, Mendibe-Bilbao MM, Meca-Lallana JE, Romero-Pinel L, Martinez-Gines ML, Arroyo R, Oreja-Guevara C, Costa-Frossard L, Carrascal P, Rodriguez-Antiguedad A.

Rev Neurol. 2019 Jun 1;68(11):468-479. doi: 10.33588/rn.6811.2019121. Review. Spanish, English.

14.

MEsenchymal StEm cells for Multiple Sclerosis (MESEMS): a randomized, double blind, cross-over phase I/II clinical trial with autologous mesenchymal stem cells for the therapy of multiple sclerosis.

Uccelli A, Laroni A, Brundin L, Clanet M, Fernandez O, Nabavi SM, Muraro PA, Oliveri RS, Radue EW, Sellner J, Soelberg Sorensen P, Sormani MP, Wuerfel JT, Battaglia MA, Freedman MS; MESEMS study group.

Trials. 2019 May 9;20(1):263. doi: 10.1186/s13063-019-3346-z.

15.

[Review of the novelties presented at the 2018 ECTRIMS Congress: 11th Post-ECTRIMS Meeting (I)].

Fernandez O, Tintore M, Saiz A, Calles-Hernandez MC, Comabella M, Ramio-Torrenta L, Oterino A, Izquierdo G, Tellez N, Garcia-Merino JA, Brieva L, Arnal-Garcia C, Aladro Y, Mendibe-Bilbao MM, Meca-Lallana JE, Romero-Pinel L, Martinez-Gines ML, Arroyo R, Oreja-Guevara C, Costa-Frossard L, Carrascal P, Rodriguez-Antiguedad A.

Rev Neurol. 2019 May 16;68(10):431-441. doi: 10.33588/rn.6810.2019120. Review. Spanish.

16.

The S1P mimetic fingolimod phosphate regulates mitochondrial oxidative stress in neuronal cells.

Martín-Montañez E, Pavia J, Valverde N, Boraldi F, Lara E, Oliver B, Hurtado-Guerrero I, Fernandez O, Garcia-Fernandez M.

Free Radic Biol Med. 2019 Jun;137:116-130. doi: 10.1016/j.freeradbiomed.2019.04.022. Epub 2019 Apr 26.

PMID:
31035004
17.

Metabolomic characterization of sunflower leaf allows discriminating genotype groups or stress levels with a minimal set of metabolic markers.

Fernandez O, Urrutia M, Berton T, Bernillon S, Deborde C, Jacob D, Maucourt M, Maury P, Duruflé H, Gibon Y, Langlade NB, Moing A.

Metabolomics. 2019 Mar 30;15(4):56. doi: 10.1007/s11306-019-1515-4.

18.

Correction to: SEOM Clinical Guideline for treatment of muscle-invasive and metastatic urothelial bladder cancer (2016).

Lázaro M, Gallardo E, Doménech M, Pinto Á, González-Del-Alba A, Puente J, Fernández O, Font A, Lainez N, Vázquez S.

Clin Transl Oncol. 2019 Jun;21(6):817. doi: 10.1007/s12094-019-02061-7.

19.

Grapevine trunk diseases under thermal and water stresses.

Songy A, Fernandez O, Clément C, Larignon P, Fontaine F.

Planta. 2019 Jun;249(6):1655-1679. doi: 10.1007/s00425-019-03111-8. Epub 2019 Feb 25. Review.

PMID:
30805725
20.

The presence and suppressive activity of myeloid-derived suppressor cells are potentiated after interferon-β treatment in a murine model of multiple sclerosis.

Melero-Jerez C, Suardíaz M, Lebrón-Galán R, Marín-Bañasco C, Oliver-Martos B, Machín-Díaz I, Fernández Ó, de Castro F, Clemente D.

Neurobiol Dis. 2019 Jul;127:13-31. doi: 10.1016/j.nbd.2019.02.014. Epub 2019 Feb 21.

21.

Resistance of Leishmania (Viannia) Panamensis to Meglumine Antimoniate or Miltefosine Modulates Neutrophil Effector Functions.

Regli IB, Fernández OL, Martínez-Salazar B, Gómez MA, Saravia NG, Tacchini-Cottier F.

Front Immunol. 2018 Dec 21;9:3040. doi: 10.3389/fimmu.2018.03040. eCollection 2018.

22.

Compassionate Use of Lumacaftor/Ivacaftor in Cystic Fibrosis: Spanish Experience.

Diab-Cáceres L, Girón-Moreno RM, Pastor-Sanz MT, Quintana-Gallego E, Delgado-Pecellín I, Blanco-Aparicio M, Maiz L, García-Clemente MM, Luna-Paredes C, Mondéjar-López P, Ruiz-de-Valbuena M, Fernández O, Barrio M, González M, López-Neyra A, Cols-I-Roig M, Palou-Rotger A, Gómez-de-Terreros-Caro FJ.

Arch Bronconeumol. 2018 Dec;54(12):614-618. doi: 10.1016/j.arbres.2018.05.004. Epub 2018 Jul 7. English, Spanish.

23.

Veterinary Students' Attitude Toward Living Kidney Donation: A Multicenter Stratified Study From Spain.

Martínez-Alarcón L, Ríos A, Ramis G, Gómez-Laguna J, Moll X, Falceto V, San Román-Acaso F, San Román-Llorens F, Quereda JJ, Herrero-Medrano JM, Mendonça L, Martin-Barrasa JL, Fernández OM, Hernández AM, Muñoz A, Ramírez P, Parrilla P.

Transplant Proc. 2018 Oct;50(8):2280-2283. doi: 10.1016/j.transproceed.2018.02.177. Epub 2018 Mar 20.

PMID:
30316341
24.

Multicenter Stratified Study From Spain About Acceptance of Living Liver Donation Among Veterinarian Students.

Martínez-Alarcón L, Ríos A, Ramis G, Gómez-Laguna J, Moll X, Falceto V, San Román-Acaso F, San Román-Llorens F, José Quereda J, Herrero-Medrano JM, Mendonça L, Martin-Barrasa JL, Fernández OM, López-Navas AI, Hernández AM, Muñoz A, Ramírez P, Parrilla P.

Transplant Proc. 2018 Oct;50(8):2272-2275. doi: 10.1016/j.transproceed.2018.02.175. Epub 2018 Mar 19.

PMID:
30316339
25.

The Quantum Mechanics of a Rolling Molecular "Nanocar".

Fernandez OE, Radhakrishnan ML.

Sci Rep. 2018 Oct 5;8(1):14878. doi: 10.1038/s41598-018-33023-8.

26.

EVALUATION OF ENEMAS CONTAINING SUCRALFATE IN TISSUE CONTENT OF MUC-2 PROTEIN IN EXPERIMENTAL MODEL OF DIVERSION COLITIS.

Fernandez OOA, Pereira JA, Campos FG, Araya CM, Marinho GE, Novo RS, Oliveira TS, Franceschi YT, Martinez CAR.

Arq Bras Cir Dig. 2018 Aug 16;31(3):e1391. doi: 10.1590/0102-672020180001e1391. English, Portuguese. Retraction in: Arq Bras Cir Dig. 2018 Dec 10;31(3):e1396.

27.

[Review of the novelties from the 2017 ECTRIMS Congress, presented at the 10th Post-ECTRIMS Meeting (II)].

Fernandez O, Tintore M, Saiz A, Calles-Hernandez MC, Comabella M, Ramio-Torrenta L, Oterino A, Izquierdo G, Tellez N, Garcia-Merino JA, Brieva L, Arnal-Garcia C, Aladro Y, Mendibe-Bilbao MM, Meca-Lallana JE, Romero-Pinel L, Ginestal R, Martinez-Gines ML, Arroyo R, Rodriguez-Antiguedad A.

Rev Neurol. 2018 Jul 15;67(2):50-62. Review. Spanish.

28.

[Review of the novelties from the 2017 ECTRIMS Congress, presented at the 10th Post-ECTRIMS Meeting (I)].

Fernandez O, Tintore M, Saiz A, Calles-Hernandez MC, Comabella M, Ramio-Torrenta L, Oterino A, Izquierdo G, Tellez N, Garcia-Merino JA, Brieva L, Arnal-Garcia C, Aladro Y, Mendibe-Bilbao MM, Meca-Lallana JE, Romero-Pinel L, Ginestal R, Martinez-Gines ML, Arroyo R, Rodriguez-Antiguedad A.

Rev Neurol. 2018 Jul 1;67(1):15-27. Review. Spanish.

29.

Adipose-derived mesenchymal stem cells (AdMSC) for the treatment of secondary-progressive multiple sclerosis: A triple blinded, placebo controlled, randomized phase I/II safety and feasibility study.

Fernández O, Izquierdo G, Fernández V, Leyva L, Reyes V, Guerrero M, León A, Arnaiz C, Navarro G, Páramo MD, Cuesta A, Soria B, Hmadcha A, Pozo D, Fernandez-Montesinos R, Leal M, Ochotorena I, Gálvez P, Geniz MA, Barón FJ, Mata R, Medina C, Caparrós-Escudero C, Cardesa A, Cuende N; Research Group Study EudraCT 2008-004015-35.

PLoS One. 2018 May 16;13(5):e0195891. doi: 10.1371/journal.pone.0195891. eCollection 2018.

30.

Untargeted Analysis of Semipolar Compounds by LC-MS and Targeted Analysis of Fatty Acids by GC-MS/GC-FID: From Plant Cultivation to Extract Preparation.

Bénard C, Acket S, Rossez Y, Fernandez O, Berton T, Gibon Y, Cabasson C.

Methods Mol Biol. 2018;1778:101-124. doi: 10.1007/978-1-4939-7819-9_8.

PMID:
29761434
31.

Attitude Toward Organ Donation and Transplantation in Veterinary Students: A Multicenter and Stratified Study in Spain.

Martínez-Alarcón L, Ríos A, Ramis G, Gómez-Laguna J, Moll X, Falceto V, San Román-Acaso F, San Román-Llorens F, Quereda JJ, Herrero-Medrano JM, Mendonça L, Martin-Barrasa JL, Fernández OM, López-Navas AI, Hernández AM, Muñoz A, Ramírez P, Parrilla P.

Transplant Proc. 2018 Mar;50(2):362-365. doi: 10.1016/j.transproceed.2017.11.068.

PMID:
29579804
32.

Financial protection in Europe: a systematic review of the literature and mapping of data availability.

Yerramilli P, Fernández Ó, Thomson S.

Health Policy. 2018 May;122(5):493-508. doi: 10.1016/j.healthpol.2018.02.006. Epub 2018 Feb 19. Review.

33.

Dabrafenib plus trametinib for compassionate use in metastatic melanoma: A STROBE-compliant retrospective observational postauthorization study.

Martín Algarra S, Soriano V, Fernández-Morales L, Berciano-Guerrero MÁ, Mujika K, Manzano JL, Puértolas Hernández T, Soria A, Rodríguez-Abreu D, Espinosa Arranz E, Medina Martínez J, Márquez-Rodas I, Rubió-Casadevall J, Ortega ME, Jurado García JM, Lecumberri Biurrun MJ, Palacio I, Rodríguez de la Borbolla Artacho M, Altozano JP, Castellón Rubio VE, García A, Luna P, Ballesteros A, Fernández O, López Martín JA, Berrocal A, Arance A.

Medicine (Baltimore). 2017 Dec;96(52):e9523. doi: 10.1097/MD.0000000000009523.

34.

Survey of diagnostic and treatment practices for multiple sclerosis (MS) in Europe. Part 2: Progressive MS, paediatric MS, pregnancy and general management.

Fernández O, Delvecchio M, Edan G, Fredrikson S, Giovannoni G, Hartung HP, Havrdova E, Kappos L, Pozzilli C, Soerensen PS, Tackenberg B, Vermersch P, Comi G.

Eur J Neurol. 2018 May;25(5):739-746. doi: 10.1111/ene.13581. Epub 2018 Feb 28.

PMID:
29356206
35.

Combination of pegylated liposomal doxorubicin plus gemcitabine in heavily pretreated metastatic breast cancer patients: Long-term results from a single institution experience.

Martin-Romano P, Baraibar I, Espinós J, Legaspi J, López-Picazo JM, Aramendía JM, Fernández OA, Santisteban M.

Breast J. 2018 Jul;24(4):473-479. doi: 10.1111/tbj.12975. Epub 2017 Dec 29.

PMID:
29286192
36.

EVALUATION OF ENEMAS CONTAINING SUCRALFATE IN TISSUE CONTENT OF MUC-2 PROTEIN IN EXPERIMENTAL MODEL OF DIVERSION COLITIS.

Fernandez OOA, Pereira JA, Campos FG, Araya CM, Marinho GE, Novo RS, Oliveira TS, Franceschi YT, Martinez CAR.

Arq Bras Cir Dig. 2017 Apr-Jun;30(2):132-138. doi: 10.1590/0102-6720201700020012. English, Portuguese.

37.

Cross-reactivity of antibodies against interferon beta in multiple sclerosis patients and interference of the JAK-STAT signaling pathway.

Hurtado-Guerrero I, Pinto-Medel MJ, Urbaneja P, Rodriguez-Bada JL, Ortega-Pinazo J, Serrano P, Fernández Ó, Leyva L, Oliver-Martos B.

Sci Rep. 2017 Nov 29;7(1):16585. doi: 10.1038/s41598-017-16828-x.

38.

Is there a change of paradigm towards more effective treatment early in the course of apparent high-risk MS?

Fernández Ó.

Mult Scler Relat Disord. 2017 Oct;17:75-83. doi: 10.1016/j.msard.2017.07.003. Epub 2017 Jul 3. Review.

39.

Treatment satisfaction with injectable disease-modifying therapies in patients with relapsing-remitting multiple sclerosis (the STICK study).

Fernández O, Duran E, Ayuso T, Hernández L, Bonaventura I, Forner M; STICK Study Investigators Group.

PLoS One. 2017 Oct 19;12(10):e0185766. doi: 10.1371/journal.pone.0185766. eCollection 2017.

40.

Profiling gene expression of antimony response genes in Leishmania (Viannia) panamensis and infected macrophages and its relationship with drug susceptibility.

Barrera MC, Rojas LJ, Weiss A, Fernandez O, McMahon-Pratt D, Saravia NG, Gomez MA.

Acta Trop. 2017 Dec;176:355-363. doi: 10.1016/j.actatropica.2017.08.017. Epub 2017 Aug 24.

41.

Global methylation correlates with clinical status in multiple sclerosis patients in the first year of IFNbeta treatment.

Pinto-Medel MJ, Oliver-Martos B, Urbaneja-Romero P, Hurtado-Guerrero I, Ortega-Pinazo J, Serrano-Castro P, Fernández Ó, Leyva L.

Sci Rep. 2017 Aug 18;7(1):8727. doi: 10.1038/s41598-017-09301-2.

42.

The HLA DRB1*03:01 allele is associated with NMO regardless of the NMO-IgG status in Brazilian patients from Rio de Janeiro.

Alvarenga MP, Fernandez O, Leyva L, Campanella L, Vasconcelos CF, Alvarenga M, Papais Alvarenga RM.

J Neuroimmunol. 2017 Sep 15;310:1-7. doi: 10.1016/j.jneuroim.2017.05.018. Epub 2017 May 31.

PMID:
28778431
43.

Efficacy and Safety of Delayed-release Dimethyl Fumarate for Relapsing-remitting Multiple Sclerosis in Prior Interferon Users: An Integrated Analysis of DEFINE and CONFIRM.

Fernández Ó, Giovannoni G, Fox RJ, Gold R, Phillips JT, Potts J, Okwuokenye M, Marantz JL.

Clin Ther. 2017 Aug;39(8):1671-1679. doi: 10.1016/j.clinthera.2017.06.012. Epub 2017 Jul 25.

44.

Estimate of the cost of multiple sclerosis in Spain by literature review.

Fernández O, Calleja-Hernández MA, Meca-Lallana J, Oreja-Guevara C, Polanco A, Pérez-Alcántara F.

Expert Rev Pharmacoecon Outcomes Res. 2017 Aug;17(4):321-333. doi: 10.1080/14737167.2017.1358617. Epub 2017 Jul 28. Review.

PMID:
28726515
45.

Review of the novelties from the 32nd ECTRIMS Congress, 2016, presented at the 9th Post-ECTRIMS Meeting (II).

Fernandez O, Oterino A, Oreja-Guevara C, Prieto JM, Mendibe-Bilbao MM, Garcia-Merino JA, Ramio-Torrenta L, Ginestal R, Meca-Lallana JE, Romero-Pinel L, Munoz D, Oliva-Nacarino P, Calles-Hernandez MC, Izquierdo G, Martinez-Gines ML, Saiz A, Comabella M, Casanova-Estruch B, Brieva L, Arroyo R, Rodriguez-Antiguedad A.

Rev Neurol. 2017 Jul 16;65(2):75-84. Spanish, English.

PMID:
28675259
46.

Leaf Starch Turnover Occurs in Long Days and in Falling Light at the End of the Day.

Fernandez O, Ishihara H, George GM, Mengin V, Flis A, Sumner D, Arrivault S, Feil R, Lunn JE, Zeeman SC, Smith AM, Stitt M.

Plant Physiol. 2017 Aug;174(4):2199-2212. doi: 10.1104/pp.17.00601. Epub 2017 Jun 29.

47.

Review of the novelties from the 32nd ECTRIMS Congress, 2016, presented at the 9th Post-ECTRIMS Meeting (I).

Fernandez O, Oterino A, Oreja-Guevara C, Prieto JM, Mendibe-Bilbao MM, Garcia-Merino JA, Ramio-Torrenta L, Ginestal R, Meca-Lallana JE, Romero-Pinel L, Munoz D, Oliva-Nacarino P, Calles-Hernandez MC, Izquierdo G, Martinez-Gines ML, Saiz A, Comabella M, Casanova-Estruch B, Brieva L, Arroyo R, Rodriguez-Antiguedad A.

Rev Neurol. 2017 Jul 1;65(1):31-40. Review. Spanish, English.

48.

[Transcultural validation in Spanish of the Actionable Bladder Symptoms Screening Tool].

Munoz-Ruiz T, Fernandez-Sanchez VE, Reyes-Garrido V, Martinez-Tomas C, Urbaneja-Romero P, Gallardo-Tur A, Guerrero-Fernandez M, Leon-Martin A, Fernandez O.

Rev Neurol. 2017 May 1;64(9):401-406. Spanish.

49.

Metabolomic signatures associated with disease severity in multiple sclerosis.

Villoslada P, Alonso C, Agirrezabal I, Kotelnikova E, Zubizarreta I, Pulido-Valdeolivas I, Saiz A, Comabella M, Montalban X, Villar L, Alvarez-Cermeño JC, Fernández O, Alvarez-Lafuente R, Arroyo R, Castro A.

Neurol Neuroimmunol Neuroinflamm. 2017 Jan 27;4(2):e321. doi: 10.1212/NXI.0000000000000321. eCollection 2017 Mar.

50.

Survey of diagnostic and treatment practices for multiple sclerosis in Europe.

Fernández O, Delvecchio M, Edan G, Fredrikson S, Gionvannoni G, Hartung HP, Havrdova E, Kappos L, Pozzilli C, Soerensen PS, Tackenberg B, Vermersch P, Comi G.

Eur J Neurol. 2017 Mar;24(3):516-522. doi: 10.1111/ene.13236. Epub 2017 Jan 31.

PMID:
28139062

Supplemental Content

Loading ...
Support Center